TY - JOUR
T1 - An in vitro system for developmental and genetic studies of Leishmania donovani phosphoglycans
AU - Goyard, Sophie
AU - Segawa, Hiroaki
AU - Gordon, Jennifer
AU - Showalter, Melissa
AU - Duncan, Robert
AU - Turco, Salvatore J.
AU - Beverley, Stephen M.
N1 - Funding Information:
We thank D. Dwyer for making the parental L. donovani 1S2D line available and sharing preliminary results, A. Descoteaux for providing L. donovani LPG2 constructs, G. Matlashewski for providing anti-A2 antisera, and M. Cunningham, A. Debrabant, K. Robinson and D. Zilberstein for discussions. This work was supported by NIH grant AI030178 to SMB and SJT.
PY - 2003/8/11
Y1 - 2003/8/11
N2 - Glycoconjugates have been shown to play important roles in Leishmania development. However, the ability to study these molecules and other processes would benefit greatly from improved methods for genetic manipulation and analysis of the amastigote stage. This is especially challenging for L. donovani, the agent of the most severe form of leishmaniasis, which can rapidly lose virulence during in vitro culture. Here we report on a clonal subline of an L. donovani 1S2D (LdBob or LdB), which differentiates readily from promastigotes to amastigotes in axenic culture, and maintains this ability during extended parasite cultivation in vitro. This derivative can be plated and transfected efficiently while grown as promastigotes or amastigotes. Importantly, LdB maintains the ability to differentiate while undergoing genetic alterations required for creation of gene knockouts and complemented lines. Like virulent L. donovani, LdB exhibits down-regulation of lipophosphoglycan (LPG) synthesis and up-regulation of A2 protein synthesis in amastigotes. We showed that knockouts of LPG2, encoding a Golgi GDP-mannose transporter, eliminated phosphoglycan synthesis in LdB axenic amastigotes. These and other data suggest that LdB axenic amastigotes will be generally useful as a differentiation model in studies of gene expression, virulence, glycoconjugate function and drug susceptibility in L. donovani.
AB - Glycoconjugates have been shown to play important roles in Leishmania development. However, the ability to study these molecules and other processes would benefit greatly from improved methods for genetic manipulation and analysis of the amastigote stage. This is especially challenging for L. donovani, the agent of the most severe form of leishmaniasis, which can rapidly lose virulence during in vitro culture. Here we report on a clonal subline of an L. donovani 1S2D (LdBob or LdB), which differentiates readily from promastigotes to amastigotes in axenic culture, and maintains this ability during extended parasite cultivation in vitro. This derivative can be plated and transfected efficiently while grown as promastigotes or amastigotes. Importantly, LdB maintains the ability to differentiate while undergoing genetic alterations required for creation of gene knockouts and complemented lines. Like virulent L. donovani, LdB exhibits down-regulation of lipophosphoglycan (LPG) synthesis and up-regulation of A2 protein synthesis in amastigotes. We showed that knockouts of LPG2, encoding a Golgi GDP-mannose transporter, eliminated phosphoglycan synthesis in LdB axenic amastigotes. These and other data suggest that LdB axenic amastigotes will be generally useful as a differentiation model in studies of gene expression, virulence, glycoconjugate function and drug susceptibility in L. donovani.
KW - Axenic amastigotes
KW - In vitro differentiation
KW - Lipophosphoglycan (LPG)
KW - Phosphoglycan molecules (PG)
KW - Protozoan parasites
KW - Transfection
KW - Virulence
UR - http://www.scopus.com/inward/record.url?scp=0141560355&partnerID=8YFLogxK
U2 - 10.1016/S0166-6851(03)00142-7
DO - 10.1016/S0166-6851(03)00142-7
M3 - Article
C2 - 14550894
AN - SCOPUS:0141560355
VL - 130
SP - 31
EP - 42
JO - Molecular and Biochemical Parasitology
JF - Molecular and Biochemical Parasitology
SN - 0166-6851
IS - 1
ER -